Contraceptive prevalence, any modern method in Mongolia
Mongolia: Contraceptive prevalence, any modern method was 45.2% in 2018. ▬ Flat
Contraceptive prevalence, any modern method in Mongolia, 1996–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Mongolia is 45.2%, measured in 2018.
The figure is down 8.9% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Mongolia peaked at 60.9% in 2005 and was at its lowest, 41.2%, in 1996.
Mongolia ranks 60th of 113 countries on this measure, in the middle of the range.
Contraceptive prevalence, any modern method in Mongolia, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1996 | 41.2% | — |
| 1998 | 45.7% | +10.9% |
| 2000 | 58.8% | +28.7% |
| 2003 | 58.4% | -0.7% |
| 2005 | 60.9% | +4.2% |
| 2008 | 49.6% | -18.5% |
| 2011 | 50.4% | +1.7% |
| 2013 | 48.2% | -4.4% |
| 2018 | 45.2% | -6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 43.5% | 41.2% | 45.7% | 2 |
| 2000s | 56.9% | 49.6% | 60.9% | 4 |
| 2010s | 47.9% | 45.2% | 50.4% | 3 |
Countries ranked near Mongolia
More health data for Mongolia
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6056 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 847.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 63 deaths (2100)
- Population ages 15-19, male, annual growth rate 9.33 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0436 units per person (2025)
- Population ages 20-24, female, annual growth rate 1.98 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0302 units per person (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Mongolia?
- Contraceptive prevalence, any modern method in Mongolia was 45.2% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Mongolia?
- The highest recorded value was 60.9% in 2005.
- What is the lowest contraceptive prevalence, any modern method recorded in Mongolia?
- The lowest recorded value was 41.2% in 1996.
- How does Mongolia rank for contraceptive prevalence, any modern method?
- Mongolia ranks 60th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Mongolia?
- Over the last ten years it is down 8.9%. The long-run trend across the full record is flat.
- Where does this Mongolia data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.